Researchers are developing recombinant influenza vaccines that may provide broadly protective immune responses. A vaccine adjuvanted with TRAC-478 has shown promise in inducing balanced and protective responses. Another adjuvant, LTA1, has also been found to improve vaccine protection against influenza in various groups, including young and old mice.